Are Anti-Beta ETFs Like BTAL Worth Owning In 2026?

When high-beta stocks stumble and markets turn volatile, AGFiQ U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) is designed to deliver. The fund goes long low-beta stocks and short high-beta stocks, betting that defensive names will outperform momentum favorites when risk appetite fades. It’s portfolio insurance with a 1.40% price tag. The problem? 2025 was the opposite ... Are Anti-Beta ETFs Like BTAL Worth Owning In 2026?The post Are Anti-Beta ETFs Like BTAL Worth Owning In 2026? appeared first on 24/7 Wall St..

Read Full Article →